Literature DB >> 9876986

Dopamine clearance in critically ill patients.

R N Juste1, L Moran, J Hooper, N Soni.   

Abstract

OBJECTIVE: To examine the validity of the low-dose "renal" dopamine regimen in critically ill patients by investigating the steady-state clearance of dopamine.
DESIGN: A prospective clinical study.
SETTING: Teaching hospital intensive care unit. PATIENTS: 48 haemodynamically stable patients receiving a dopamine infusion.
INTERVENTIONS: Sampling of arterial blood and dopamine infusates. MEASUREMENT AND
RESULTS: Plasma and infusate dopamine levels were measured by liquid chromatography with electrochemical detection. Steady-state clearance was determined by dividing the actual infusion rate by the steady-state plasma concentration. Dopamine clearance for the whole group was 46.4 +/- 35.9 ml/kg per min (mean +/- SD), which is significantly lower than 70 +/- 15.2 ml/kg per min reported for elective surgical patients (p = 0.01). Twelve patients with renal dysfunction had significantly lower dopamine clearances (36 +/- 16.6 ml/kg per min) than the remaining 36 patients (61 +/- 38.5 ml/kg per min, p = 0.022). There was a very poor correlation between plasma dopamine level and infusion rate for the group as a whole (r = 0.47), and this worsened (r = 0.31) when only those patients on a "renal" dose of 2-5 microg/kg per min were considered (n = 30).
CONCLUSION: Plasma dopamine clearance is lower in critically ill patients and there is a large interindividual variation. It is therefore impossible to predict the plasma level from the infusion rate. Consequently, the concept of a selective renovascular low-dose dopamine infusion is invalid in critically ill patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9876986     DOI: 10.1007/s001340050747

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  8 in total

Review 1.  [Effects of dopamine on cellular and humoral immune responses in septic patients].

Authors:  G Beck; C Hanusch; P Brinkkoetter; N Rafat; J Schulte; K van Ackern; B Yard
Journal:  Anaesthesist       Date:  2005-10       Impact factor: 1.041

Review 2.  Clinical Pharmacology Studies in Critically Ill Children.

Authors:  Nilay Thakkar; Sara Salerno; Christoph P Hornik; Daniel Gonzalez
Journal:  Pharm Res       Date:  2016-09-01       Impact factor: 4.200

Review 3.  Adjunctive drug treatment in severe hypoxic respiratory failure.

Authors:  S Elsasser; H Schächinger; W Strobel
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

Review 4.  Acute renal failure in children: aetiology and management.

Authors:  G Filler
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 5.  Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies.

Authors:  Ilan Goldenberg; Shlomi Matetzky
Journal:  CMAJ       Date:  2005-05-24       Impact factor: 8.262

6.  N-octanoyl dopamine, a non-hemodyanic dopamine derivative, for cell protection during hypothermic organ preservation.

Authors:  Ralf M Lösel; Ulf Schnetzke; Paul T Brinkkoetter; Hui Song; Grietje Beck; Peter Schnuelle; Simone Höger; Martin Wehling; Benito A Yard
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

Review 7.  Pharmacokinetics and pharmacodynamics of intravenous inotropic agents.

Authors:  Lasse A Lehtonen; Saila Antila; Pertti J Pentikäinen
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

8.  Pharmacokinetics and pharmacodynamics of dopamine and norepinephrine in critically ill head-injured patients.

Authors:  Andrew J Johnston; Luzius A Steiner; Mark O'Connell; Dot A Chatfield; Arun K Gupta; David K Menon
Journal:  Intensive Care Med       Date:  2003-10-29       Impact factor: 17.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.